- Home
- PHIO vs BHAT Comparison
PHIO vs BHAT Comparison
Compare PHIO & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- BHAT
- Stock Information
- Founded
- PHIO 2011
- BHAT 2010
- Country
- PHIO United States
- BHAT China
- Employees
- PHIO N/A
- BHAT N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- BHAT Recreational Games/Products/Toys
- Sector
- PHIO Health Care
- BHAT Consumer Discretionary
- Exchange
- PHIO Nasdaq
- BHAT Nasdaq
- Market Cap
- PHIO 12.1M
- BHAT 12.7M
- IPO Year
- PHIO N/A
- BHAT 2019
- Fundamental
- Price
- PHIO $2.04
- BHAT $1.74
- Analyst Decision
- PHIO Strong Buy
- BHAT
- Analyst Count
- PHIO 3
- BHAT 0
- Target Price
- PHIO $10.67
- BHAT N/A
- AVG Volume (30 Days)
- PHIO 139.7K
- BHAT 133.7K
- Earning Date
- PHIO 08-14-2025
- BHAT 04-30-2025
- Dividend Yield
- PHIO N/A
- BHAT N/A
- EPS Growth
- PHIO N/A
- BHAT N/A
- EPS
- PHIO N/A
- BHAT N/A
- Revenue
- PHIO N/A
- BHAT $18,724,190.00
- Revenue This Year
- PHIO N/A
- BHAT N/A
- Revenue Next Year
- PHIO N/A
- BHAT N/A
- P/E Ratio
- PHIO N/A
- BHAT N/A
- Revenue Growth
- PHIO N/A
- BHAT N/A
- 52 Week Low
- PHIO $0.97
- BHAT $1.51
- 52 Week High
- PHIO $9.79
- BHAT $45.00
- Technical
- Relative Strength Index (RSI)
- PHIO 42.33
- BHAT 52.54
- Support Level
- PHIO $1.96
- BHAT $1.60
- Resistance Level
- PHIO $2.13
- BHAT $1.92
- Average True Range (ATR)
- PHIO 0.10
- BHAT 0.13
- MACD
- PHIO 0.01
- BHAT 0.01
- Stochastic Oscillator
- PHIO 44.83
- BHAT 54.88
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.